Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in SPRB — Spruce Biosciences, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to SPRB Full portfolio

Position in SPRB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$125,766
+$125,654 QoQ
Shares Held
2,329
Ownership
0.081%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 63 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SPRB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. SPRB ranks #281 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in SPRB

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $125,766 2,329
2024-03-31 $112 143
2023-12-31 $413 141
2023-09-30 $293 130
2023-06-30 $399 186
2023-03-31 $148 67
2022-12-31 $510 466
2022-09-30 $909 664
2022-06-30 $1,842 1,059
2022-03-31 $9,752 4,852
2021-12-31 $42,258 9,475
2021-09-30 $65,622 10,919
2021-06-30 $78,851 7,034
2021-03-31 $36,088 2,174
2020-12-31 $90,530 3,724